Back to Brown Brothers Harriman & Co. Brown Brothers Harriman & Co.

NVAXNVAX

Showing 4 of 25 quarters

Position history for Brown Brothers Harriman & Co.Brown Brothers Harriman & Co.'s holdings in Novavax, Inc.

No. Brown Brothers Harriman exited its NVAX (Novavax) position in Q2 2025. Its Q1 2025 13F listed 125 shares worth $801. Brown Brothers Harriman already held NVAX in its Q2 2019 13F, the earliest on record, and held it in 24 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1,579

Total Shares Change

-125

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$6.30
0
2025-Q1
Unchanged
125
0.0%
$8010.0%$6.41
0
2024-Q4
Unchanged
125
0.0%
$1,0050.0%$8.04
0
2024-Q3
Unchanged
125
0.0%
$1,5790.0%$12.63
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used